These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
84 related articles for article (PubMed ID: 18762876)
1. High expression of human clotting factor IX cDNA in myoblasts C2C12 cells and C3H mice. Wang H; Bao Y; Lu D; Qiu X; Xue J Sci China C Life Sci; 1997 Aug; 40(4):371-8. PubMed ID: 18762876 [TBL] [Abstract][Full Text] [Related]
2. Construction of human factor IX expression vectors in retroviral vector frames optimized for muscle cells. Wang JM; Zheng H; Sugahara Y; Tan J; Yao SN; Olson E; Kurachi K Hum Gene Ther; 1996 Sep; 7(14):1743-56. PubMed ID: 8886845 [TBL] [Abstract][Full Text] [Related]
3. [Exploration of high expressions of retroviral vectors containing hFIX minigene in murine myoblast cells]. Hou J; Wang J; Min B Zhonghua Xue Ye Xue Za Zhi; 2001 Mar; 22(3):121-4. PubMed ID: 11877060 [TBL] [Abstract][Full Text] [Related]
4. Construction and high expression of retroviral vector with human clotting factor IX cDNA in vitro. Lu D; Qiu X; Zheng B; Qiu X; Xue J Sci China B; 1995 Jun; 38(6):705-12. PubMed ID: 7626200 [TBL] [Abstract][Full Text] [Related]
5. Sustained and therapeutic levels of human factor IX in hemophilia B mice implanted with microcapsules: key role of encapsulated cells. Wen J; Vargas AG; Ofosu FA; Hortelano G J Gene Med; 2006 Mar; 8(3):362-9. PubMed ID: 16311997 [TBL] [Abstract][Full Text] [Related]
6. Increment of hFIX expression with endogenous intron 1 in vitro. Zheng B; Qiu XY; Tan M; Xing YN; Lo D; Xue JL; Qiu XF Cell Res; 1997 Jun; 7(1):21-9. PubMed ID: 9261559 [TBL] [Abstract][Full Text] [Related]
7. Implantation of autologous skin fibroblast genetically modified to secrete clotting factor IX partially corrects the hemorrhagic tendencies in two hemophilia B patients. Qiu X; Lu D; Zhou J; Wang J; Yang J; Meng P; Hsueh JL Chin Med J (Engl); 1996 Nov; 109(11):832-9. PubMed ID: 9275366 [TBL] [Abstract][Full Text] [Related]
8. Primary myoblast-mediated gene transfer: persistent expression of human factor IX in mice. Yao SN; Smith KJ; Kurachi K Gene Ther; 1994 Mar; 1(2):99-107. PubMed ID: 7584074 [TBL] [Abstract][Full Text] [Related]
9. Encapsulated human primary myoblasts deliver functional hFIX in hemophilic mice. Wen J; Xu N; Li A; Bourgeois J; Ofosu FA; Hortelano G J Gene Med; 2007 Nov; 9(11):1002-10. PubMed ID: 17868187 [TBL] [Abstract][Full Text] [Related]
10. Skeletal muscle-specific expression of human blood coagulation factor IX rescues factor IX deficiency mouse by AAV-mediated gene transfer. Lai L; Chen L; Wang J; Zhou H; Lu D; Wang Q; Gao X; Qiu X; Xue J Sci China C Life Sci; 1999 Dec; 42(6):628-34. PubMed ID: 18726486 [TBL] [Abstract][Full Text] [Related]
11. [Preparation of rAAV2/hFIX and experimentally application to gene therapy for hemophilia B]. Peng JQ; Dong XY; Peng M; Chen L; Tan SP; Yuan H; Chen FP; Xue JL; Wu XB Zhonghua Xue Ye Xue Za Zhi; 2004 Sep; 25(9):513-8. PubMed ID: 15569526 [TBL] [Abstract][Full Text] [Related]
12. Hybrid retroviral vector with MCK enhancers inserted in LTR for stable and specific expression of human factor IX in skeletal muscle. Wang JM; Hou J; Qiu XF; Kurachi K; Xue JL Chin Med J (Engl); 2004 Jun; 117(6):893-8. PubMed ID: 15198894 [TBL] [Abstract][Full Text] [Related]
13. Retroviral vector-modified bone marrow stromal cells secrete biologically active factor IX in vitro and transiently deliver therapeutic levels of human factor IX to the plasma of dogs after reinfusion. Cherington V; Chiang GG; McGrath CA; Gaffney A; Galanopoulos T; Merrill W; Bizinkauskas CB; Hansen M; Sobolewski J; Levine PH; Greenberger JS; Hurwitz DR Hum Gene Ther; 1998 Jul; 9(10):1397-407. PubMed ID: 9681411 [TBL] [Abstract][Full Text] [Related]
14. [Lasting expression of hF IX mediated by myoblasts in mice]. Wang H; Yang X; Bao Y; Xue J Zhonghua Xue Ye Xue Za Zhi; 1997 Sep; 18(9):471-3. PubMed ID: 15625839 [TBL] [Abstract][Full Text] [Related]
15. Persistent systemic production of human factor IX in mice by skeletal myoblast-mediated gene transfer: feasibility of repeat application to obtain therapeutic levels. Wang JM; Zheng H; Blaivas M; Kurachi K Blood; 1997 Aug; 90(3):1075-82. PubMed ID: 9242538 [TBL] [Abstract][Full Text] [Related]
16. [Splicing and stability of intron in the expression retroviral vector with human clotting factor IX]. Xing YN; Lu DR; Gao XB; Qiu XF; Xue JL Yi Chuan Xue Bao; 1998 Dec; 25(6):471-7. PubMed ID: 10465892 [TBL] [Abstract][Full Text] [Related]
17. Efficient delivery of human clotting factor IX after injection of lentiviral vectors in utero. Chen XG; Zhu HZ; Gong JL; Li F; Xue JL Acta Pharmacol Sin; 2004 Jun; 25(6):789-93. PubMed ID: 15169633 [TBL] [Abstract][Full Text] [Related]
18. Expression and regulation of hFIX minigene and cDNA driven by beta-casein gene in mouse mammary gland. Zhang K; Jiang P; Lu D; Huang W; Chen L; Xue J; Qiu X Sci China C Life Sci; 1998 Aug; 41(4):406-12. PubMed ID: 18726258 [TBL] [Abstract][Full Text] [Related]
19. A study of gene transfer and expression of human clotting factor IX in hemophilia B mice mediated by mini-adenoviral vector. Gao X; Ye C; Shi D; Chen L; Qiu X; Xue J Sci China C Life Sci; 2003 Dec; 46(6):631-40. PubMed ID: 18758720 [TBL] [Abstract][Full Text] [Related]
20. [The transfer and expression of human clotting factor IX in muscle mediated by electroporation]. Wang H; Wang F; Chen L; Xue J; Lu D Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2001 Dec; 18(6):476-8. PubMed ID: 11774220 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]